ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000163357 | DCST1 | DC-STAMP domain containing 1 | [
"Q5T197"
] | 1 | 155033824-155050930 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA060314"
] | [
"FLJ32785"
] | [
"Enzymes",
"Predicted membrane proteins"
] | [
"Immunity",
"Innate immunity",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Principal piece"
] | [
"Acrosome",
"Equatorial segment"
] | [] | [] | Approved | Uncertain | null | 1 | null | null | null | null | Cluster 45: Non-specific - Nuclear processes | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 47: Testis - Mixed function | Group enriched | Detected in some | 5 | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,794 | 7 |
ENSG00000163359 | COL6A3 | Collagen type VI alpha 3 chain | [
"P12111"
] | 2 | 237324003-237414328 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA010007",
"HPA010080"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion"
] | [
"Protease inhibitor",
"Serine protease inhibitor"
] | [
"Congenital muscular dystrophy",
"Disease variant",
"Dystonia"
] | [
"Endoplasmic reticulum"
] | [
"Vesicles"
] | [
"Secreted to extracellular matrix"
] | [
"Cell adhesion"
] | Approved | Supported | null | null | null | null | null | Cluster 29: Forebrain - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 10,795 | 7 |
ENSG00000163362 | INAVA | Innate immunity activator | [
"Q3KP66"
] | 1 | 200891048-200915742 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027499",
"HPA027511",
"HPA079622"
] | [
"C1orf106",
"FLJ10901"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Immunity",
"Innate immunity"
] | [] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Nuclear bodies"
] | [] | [] | Supported | Uncertain | null | 27 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 77: Intestine - Digestion | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 10,796 | 2 |
ENSG00000163374 | YY1AP1 | YY1 associated protein 1 | [
"Q9H869"
] | 1 | 155659443-155689000 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006986",
"HPA064249"
] | [
"HCCA2",
"YAP",
"YY1AP"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [] | [] | [
"Nucleoli fibrillar center"
] | [] | [] | [] | Approved | Uncertain | null | 12 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 16: Non-specific - Transcription | Cluster 45: Non-specific - Nuclear processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 10,797 | 9 |
ENSG00000163376 | KBTBD8 | Kelch repeat and BTB domain containing 8 | [
"Q8NFY9"
] | 3 | 66998307-67011210 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041285",
"HPA069190"
] | [
"KIAA1842",
"TA-KRP"
] | [
"Predicted intracellular proteins"
] | [
"Translation regulation",
"Ubl conjugation pathway"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 13 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 23: Choroid plexus - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 75: Non-specific - Chaperones and protein folding | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 10,798 | 4 |
ENSG00000163377 | TAFA4 | TAFA chemokine like family member 4 | [
"Q96LR4"
] | 3 | 68731766-68953297 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"FAM19A4",
"TAFA-4"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Secreted in brain"
] | [
"No annotated function"
] | null | null | null | 1 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in some | 8 | Cancer enriched | Detected in single | 4 | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,799 | 8 |
ENSG00000163378 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | [
"Q5NDL2"
] | 3 | 68975217-69013684 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA019460"
] | [
"AER61",
"C3orf64",
"FLJ33770"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Disease variant"
] | [
"Nucleoplasm",
"Nuclear membrane"
] | [
"Cytosol"
] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Approved | Approved | null | null | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 42: Choroid plexus - Mitochondria | Cluster 48: Adipocytes & Endothelial cells - Angiogenesis | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,800 | 8 |
ENSG00000163380 | LMOD3 | Leiomodin 3 | [
"Q0VAK6"
] | 3 | 69106065-69123032 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036034"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Nemaline myopathy"
] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | Cluster 32: Basophils - Transcription | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 33: Sarcoma - Muscle contraction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 30: Skeletal muscle - Striated muscle contraction | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Low cancer specificity | Detected in some | null | Group enriched | Detected in many | 9 | Low immune cell specificity | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 10,801 | 2 |
ENSG00000163382 | NAXE | NAD(P)HX epimerase | [
"Q8NCW5"
] | 1 | 156591756-156609507 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043766",
"HPA048164"
] | [
"AIBP",
"APOA1BP",
"MGC119143",
"MGC119144",
"MGC119145",
"YJEFN1"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted secreted proteins"
] | [
"Lipid transport",
"Transport"
] | [
"Isomerase"
] | [
"Disease variant",
"Neurodegeneration"
] | [
"Nucleoplasm"
] | [
"Vesicles",
"Cytosol"
] | [
"Secreted to blood"
] | [
"Transport"
] | Approved | Enhanced | null | 4 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 10: Ciliated cells - Ion channel activity | Cluster 97: Non-specific - Cellular respiration | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 10,802 | 2 |
ENSG00000163389 | POGLUT1 | Protein O-glucosyltransferase 1 | [
"Q8NBL1"
] | 3 | 119468963-119494708 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037855",
"HPA037856"
] | [
"9630046K23Rik",
"C3orf9",
"hCLP46",
"KDELCL1",
"KTELC1",
"MDS010",
"MDSRP",
"MGC32995",
"Rumi"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Gastrulation"
] | [
"Developmental protein",
"Glycosyltransferase",
"Transferase"
] | [
"Disease variant",
"Limb-girdle muscular dystrophy"
] | [
"Endoplasmic reticulum"
] | [] | [
"Intracellular and membrane"
] | [
"Developmental protein"
] | Supported | Approved | null | 28 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 82: Dendritic cells - Antigen presentation | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 10,803 | 2 |
ENSG00000163393 | SLC22A15 | Solute carrier family 22 member 15 | [
"Q8IZD6"
] | 1 | 115976513-116070054 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA019785"
] | [
"FLIPT1"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Amino-acid transport",
"Ion transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 8 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,804 | 5 |
ENSG00000163394 | CCKAR | Cholecystokinin A receptor | [
"P32238"
] | 4 | 26481396-26490484 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA073900"
] | [] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | null | null | null | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 64: Connective tissue cells - ECM organization | Cluster 97: Non-specific - Cellular respiration | Cluster 60: Stomach - Digestion | Group enriched | Detected in some | 7 | Group enriched | Detected in some | 5 | Cancer enriched | Detected in single | 5 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,805 | 4 |
ENSG00000163395 | IGFN1 | Immunoglobulin like and fibronectin type III domain containing 1 | [
"Q86VF2"
] | 1 | 201190824-201228952 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA050415"
] | [
"DKFZp434B1231",
"EEF1A2BP1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Midbody ring"
] | [] | [] | [] | Approved | Enhanced | null | 2 | Yes | null | null | Cluster 29: Forebrain - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 19: Skeletal muscle - Striated muscle contraction | Tissue enriched | Detected in some | 7 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 6 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,806 | 4 |
ENSG00000163399 | ATP1A1 | ATPase Na+/K+ transporting subunit alpha 1 | [
"P05023"
] | 1 | 116372668-116410261 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB018702",
"CAB069993"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Essential proteins",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Potassium transport",
"Sodium transport",
"Sodium/potassium transport",
"Transport"
] | [
"Translocase"
] | [
"Cancer-related genes",
"Charcot-Marie-Tooth disease",
"Epilepsy",
"FDA approved drug targets",
"Intellectual disability",
"Neurodegeneration",
"Neuropathy",
"Primary hypomagnesemia"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | [] | Approved | Enhanced | null | 68 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 70: DU4475 - Unknown function | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,807 | 2 |
ENSG00000163406 | SLC15A2 | Solute carrier family 15 member 2 | [
"Q16348"
] | 3 | 121894401-121944188 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"PEPT2"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Immunity",
"Innate immunity",
"Peptide transport",
"Protein transport",
"Symport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | null | null | 21 | null | null | Cluster 32: Basophils - Transcription | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 22: Epididymis - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [
"Lung Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,808 | 6 |
ENSG00000163412 | EIF4E3 | Eukaryotic translation initiation factor 4E family member 3 | [
"Q8N5X7"
] | 3 | 71675414-71754773 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA058649",
"HPA076465"
] | [
"MGC39820"
] | [
"Predicted intracellular proteins"
] | [
"Protein biosynthesis",
"Translation regulation"
] | [
"Initiation factor",
"RNA-binding"
] | [] | [
"Nucleoli fibrillar center"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 105: Non-specific - Mixed function | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 10,809 | 2 |
ENSG00000163421 | PROK2 | Prokineticin 2 | [
"Q9HC23"
] | 3 | 71771655-71785206 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041408"
] | [
"BV8",
"KAL4",
"MIT1",
"PK2"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted secreted proteins"
] | [
"Biological rhythms"
] | [
"Neuropeptide"
] | [
"Disease variant",
"Hypogonadotropic hypogonadism",
"Kallmann syndrome"
] | [] | [] | [
"Secreted to blood"
] | [
"Neuropeptide"
] | null | Approved | null | 4 | null | null | Cluster 4: Neutrophils - Degranulation | Cluster 12: Non-specific - Vasculature | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 15: Bone marrow - Innate immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 13 | Immune cell enriched | Detected in many | 50 | 0 | 0 | 0 | [] | [] | [] | 10,810 | 5 |
ENSG00000163424 | TEX55 | Testis expressed 55 | [
"Q96M34"
] | 3 | 119146151-119160042 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062468"
] | [
"C3orf30",
"FLJ32859",
"TSCPA"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Vesicles",
"Plasma membrane",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 1 | null | null | null | null | Cluster 10: Ciliated cells - Ion channel activity | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in single | 290 | Not detected | Not detected | null | Not detected | Not detected | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,811 | 5 |
ENSG00000163428 | LRRC58 | Leucine rich repeat containing 58 | [
"Q96CX6"
] | 3 | 120324509-120349354 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA057574"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 2 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 18: Adrenal cortex cells - Steroidogensis | Cluster 4: Adrenal gland - Steroid metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 10,812 | 3 |
ENSG00000163430 | FSTL1 | Follistatin like 1 | [
"Q12841"
] | 3 | 120392293-120450993 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035251",
"HPA040815"
] | [
"FRP",
"FSL1",
"OCC-1",
"OCC1",
"tsc36"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Heparin-binding"
] | [] | [
"Vesicles"
] | [
"Golgi apparatus",
"Cytosol"
] | [
"Secreted to blood"
] | [
"Other"
] | Approved | Uncertain | null | 19 | null | null | null | Cluster 8: Immune cells - Immune response | Cluster 64: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 14 | 0 | 0 | 0 | [] | [] | [] | 10,813 | 2 |
ENSG00000163431 | LMOD1 | Leiomodin 1 | [
"P29536"
] | 1 | 201896456-201946588 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028325",
"HPA028435",
"HPA030097"
] | [
"1D",
"64kD",
"D1",
"SM-LMOD",
"SMLMOD"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [
"Disease variant"
] | [
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 1 | No | No | null | Cluster 13: Oligodendrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,814 | 5 |
ENSG00000163440 | PDCL2 | Phosducin like 2 | [
"Q8N4E4"
] | 4 | 55556519-55592245 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048260",
"HPA072384"
] | [
"GCPHLP"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [] | [] | [
"Microtubules"
] | [
"Centrosome"
] | [] | [] | Approved | Enhanced | null | 1 | null | null | null | null | Cluster 24: Non-specific - Unknown function | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in single | 206 | Not detected | Not detected | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 17 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | 10,816 | 9 |
ENSG00000163444 | TMEM183A | Transmembrane protein 183A | [
"Q8IXX5"
] | 1 | 203007374-203024848 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA072607"
] | [
"C1orf37"
] | [
"Essential proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Nucleoplasm",
"Cell Junctions"
] | [] | [] | Approved | null | null | 11 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 1: Neurons - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,817 | 8 |
ENSG00000163449 | TMEM169 | Transmembrane protein 169 | [
"Q96HH4"
] | 2 | 216081866-216102783 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA070657",
"HPA074877"
] | [
"FLJ34263"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Focal adhesion sites"
] | [] | [] | [] | Approved | Enhanced | null | null | null | null | Cluster 20: Non-specific - DNA binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in many | 5 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 10,818 | 8 |
ENSG00000163453 | IGFBP7 | Insulin like growth factor binding protein 7 | [
"Q16270"
] | 4 | 57030773-57110385 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002196",
"CAB020668"
] | [
"FSTL2",
"IGFBP-7",
"MAC25",
"PSF"
] | [
"Disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion"
] | [
"Growth factor binding"
] | [] | [
"Golgi apparatus"
] | [] | [
"Secreted to blood"
] | [
"Cell adhesion"
] | Approved | Approved | null | 2 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 36: Choroid plexus - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 110: Mural cells - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Stomach Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 10,819 | 1 |
ENSG00000163462 | TRIM46 | Tripartite motif containing 46 | [
"Q7Z4K8"
] | 1 | 155173787-155184971 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA030391",
"HPA055583"
] | [
"FLJ23229",
"TRIFIC"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Microtubule ends",
"Mitotic spindle",
"Primary cilium transition zone"
] | [
"Cytokinetic bridge",
"Centrosome",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | null | Yes | null | null | Cluster 34: Non-specific - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,820 | 4 |
ENSG00000163463 | KRTCAP2 | Keratinocyte associated protein 2 | [
"Q8N6L1"
] | 1 | 155169408-155173475 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"KCP2"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | 33 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 21: Non-specific - Metabolism | Cluster 45: Non-specific - Nuclear processes | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 10,821 | 2 |
ENSG00000163464 | CXCR1 | C-X-C motif chemokine receptor 1 | [
"P25024"
] | 2 | 218162841-218166962 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031991"
] | [
"CD181",
"CDw128a",
"CKR-1",
"CMKAR1",
"IL8RA"
] | [
"Cancer-related genes",
"CD markers",
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Chemotaxis"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Cancer-related genes"
] | [] | [] | [] | [] | null | Uncertain | null | 4 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 12: Non-specific - Vasculature | Cluster 49: HMC-1 - Innate immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Not detected | Not detected | null | Low cancer specificity | Detected in single | null | Cell type enriched | Detected in some | 14 | Immune cell enriched | Detected in many | 14 | 0 | 0 | 0 | [] | [] | [] | 10,822 | 2 |
ENSG00000163466 | ARPC2 | Actin related protein 2/3 complex subunit 2 | [
"O15144"
] | 2 | 218217141-218254356 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001994",
"HPA008352",
"HPA052703"
] | [
"ARC34",
"p34-Arc"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 81 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 29: Forebrain - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,823 | 2 |
ENSG00000163467 | TSACC | TSSK6 activating cochaperone | [
"Q96A04"
] | 1 | 156337314-156346995 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029897"
] | [
"C1orf182",
"SIP",
"SSTK-IP"
] | [
"Predicted intracellular proteins"
] | [] | [
"Chaperone"
] | [] | [
"Nuclear bodies"
] | [
"Nucleoplasm"
] | [] | [] | Approved | null | null | 6 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in some | 379 | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 8 | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 10,824 | 2 |
ENSG00000163468 | CCT3 | Chaperonin containing TCP1 subunit 3 | [
"P49368"
] | 1 | 156308968-156367873 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006543",
"HPA074177"
] | [
"Cctg",
"TRIC5"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Chaperone",
"Hydrolase"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Cytosol"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 215 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 55: Non-specific - Transcription | Cluster 45: Non-specific - Nuclear processes | Cluster 17: Non-specific - RNA processing | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Glioblastoma Multiforme"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 10,825 | 8 |
ENSG00000163472 | TMEM79 | Transmembrane protein 79 | [
"Q9BSE2"
] | 1 | 156282935-156293185 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA055214"
] | [
"FLJ16057",
"FLJ32254",
"MATT",
"MGC13102"
] | [
"Disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoli fibrillar center"
] | [] | [] | [] | Approved | Enhanced | null | 41 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 13: Oligodendrocytes - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,826 | 5 |
ENSG00000163479 | SSR2 | Signal sequence receptor subunit 2 | [
"P43308"
] | 1 | 156009048-156020951 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TLAP",
"TRAPB"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | null | null | 3 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 12: Non-specific - Vasculature | Cluster 51: Myeloma - Immunoglobulins | Cluster 8: Non-specific - Secretory pathway | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,827 | 8 |
ENSG00000163481 | RNF25 | Ring finger protein 25 | [
"Q96BH1"
] | 2 | 218663892-218672002 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036420",
"HPA036421"
] | [
"AO7",
"FLJ13906"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm",
"Actin filaments"
] | [] | [] | Approved | Uncertain | null | 32 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 97: Non-specific - Cellular respiration | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,828 | 4 |
ENSG00000163482 | STK36 | Serine/threonine kinase 36 | [
"Q9NRP7"
] | 2 | 218672069-218702716 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027409",
"HPA027453",
"HPA030058"
] | [
"FU",
"KIAA1278"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cilium biogenesis/degradation"
] | [
"Developmental protein",
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Ciliopathy",
"Primary ciliary dyskinesia"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 15 | null | null | null | Cluster 17: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 21: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,829 | 4 |
ENSG00000163485 | ADORA1 | Adenosine A1 receptor | [
"P30542"
] | 1 | 203090654-203167405 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044383",
"CAB080543"
] | [
"RDC7"
] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [
"Plasma membrane"
] | [
"Primary cilium"
] | [] | [] | Supported | Approved | null | 9 | null | null | null | Cluster 49: Hindbrain - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 57: Podocytes - Glomerular filtration | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 10,830 | 1 |
ENSG00000163491 | NEK10 | NIMA related kinase 10 | [
"Q6ZWH5"
] | 3 | 27106484-27369460 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038941"
] | [
"FLJ32685"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Ciliopathy",
"Disease variant",
"Primary ciliary dyskinesia"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 29: Forebrain - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in many | 5 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,831 | 9 |
ENSG00000163497 | FEV | FEV transcription factor, ETS family member | [
"Q99581"
] | 2 | 218981087-218985184 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067679"
] | [
"Pet-1"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Neurogenesis",
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [] | [] | [] | Supported | null | Supported | null | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 96: Enteroendocrine cells - Neuropeptide signaling | Cluster 77: Intestine - Digestion | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 16 | Group enriched | Detected in some | 8 | Cell type enriched | Detected in some | 7 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,833 | 3 |
ENSG00000163499 | CRYBA2 | Crystallin beta A2 | [
"P53672"
] | 2 | 218990189-218993422 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062293"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"Eye lens protein"
] | [
"Cataract",
"Disease variant"
] | [] | [] | [] | [] | null | Supported | null | 23 | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 96: Enteroendocrine cells - Neuropeptide signaling | Cluster 8: Pancreas - Proteolysis | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in some | 21 | Group enriched | Detected in some | 26 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 10,834 | 2 |
ENSG00000163501 | IHH | Indian hedgehog signaling molecule | [
"Q14623"
] | 2 | 219054424-219060921 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"BDA1",
"HHG2"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [
"Developmental protein",
"Hydrolase",
"Protease",
"Transferase"
] | [
"Disease variant",
"Dwarfism"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Developmental protein"
] | null | null | null | 1 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 96: Enteroendocrine cells - Neuropeptide signaling | Cluster 77: Intestine - Digestion | Group enriched | Detected in some | 4 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Papillary Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 10,835 | 1 |
ENSG00000163507 | CIP2A | Cellular inhibitor of PP2A | [
"Q8TCG1"
] | 3 | 108549864-108589644 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA039570"
] | [
"KIAA1524"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"DNA damage"
] | [] | [] | [
"Cytosol"
] | [
"Plasma membrane",
"Centrosome",
"Basal body"
] | [] | [] | Approved | Approved | null | 19 | null | Yes | null | Cluster 31: Non-specific - Transcription | Cluster 63: Non-specific - Protein processing | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Low tissue specificity | Detected in some | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,836 | 5 |
ENSG00000163508 | EOMES | Eomesodermin | [
"O95936"
] | 3 | 27715949-27722711 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028896"
] | [
"TBR2"
] | [
"Disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Adaptive immunity",
"Differentiation",
"Gastrulation",
"Immunity",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Golgi apparatus",
"Cytosol"
] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 15: NK-cells - Unknown function | Cluster 35: Non-specific - DNA binding | Cluster 50: Lymphoma - Unknown function | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 61: Non-specific - Transcription | Group enriched | Detected in some | 6 | Group enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 6 | Group enriched | Detected in many | 7 | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 10,837 | 7 |
ENSG00000163510 | CWC22 | CWC22 spliceosome associated protein homolog | [
"Q9HCG8"
] | 2 | 179944876-180007297 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036748"
] | [
"EIF4GL",
"fSAPb",
"KIAA1604",
"NCM"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [] | [] | [
"Nuclear speckles"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 20 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 31: Non-specific - Transcription | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 17: Non-specific - RNA processing | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 10,838 | 7 |
ENSG00000163512 | AZI2 | 5-azacytidine induced 2 | [
"Q9H6S1"
] | 3 | 28315003-28349050 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035258"
] | [
"AZ2",
"FLJ21939",
"NAP1"
] | [
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 15 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 21: Non-specific - Metabolism | Cluster 8: Non-specific - Basic cellular processes | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 73: Brain - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,839 | 4 |
ENSG00000163513 | TGFBR2 | Transforming growth factor beta receptor 2 | [
"P37173"
] | 3 | 30606601-30694142 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB073537",
"HPA074821"
] | [
"MFS2",
"TBR-ii",
"TBRII"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Apoptosis",
"Differentiation",
"Growth regulation"
] | [
"Kinase",
"Receptor",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Aortic aneurysm",
"Cancer-related genes",
"Craniosynostosis",
"Disease variant",
"FDA approved drug targets",
"Hereditary nonpolyposis colorectal cancer"
] | [
"Plasma membrane"
] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | Enhanced | null | null | 94 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 42: Choroid plexus - Mitochondria | Cluster 44: Connective tissue cells - ECM organization | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,840 | 9 |
ENSG00000163515 | RETNLB | Resistin like beta | [
"Q9BQ08"
] | 3 | 108743424-108757410 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA049152"
] | [
"FIZZ2",
"HXCP2",
"RELMb"
] | [
"Predicted secreted proteins",
"Transporters"
] | [] | [
"Hormone"
] | [] | [
"Endoplasmic reticulum"
] | [] | [
"Secreted to blood"
] | [
"Hormone"
] | Uncertain | Enhanced | null | null | null | null | null | null | Cluster 10: Ciliated cells - Ion channel activity | Cluster 70: Intestinal goblet cells - Mucin production | Cluster 17: Intestine - Digestion | Tissue enriched | Detected in some | 57 | Cancer enhanced | Detected in single | null | Group enriched | Detected in some | 11 | Cell type enriched | Detected in some | 18 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,841 | 8 |
ENSG00000163516 | ANKZF1 | Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 | [
"Q9H8Y5"
] | 2 | 219229783-219236679 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035208"
] | [
"FLJ10415",
"Vms1",
"ZNF744"
] | [
"Predicted intracellular proteins"
] | [] | [
"Endonuclease",
"Hydrolase",
"Nuclease"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies",
"Cytosol"
] | [] | [] | Approved | Approved | null | 13 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 6: Non-specific - Immune response | Cluster 15: Kidney cancer - Membrane components | Cluster 7: Non-specific - Transcription | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,842 | 5 |
ENSG00000163517 | HDAC11 | Histone deacetylase 11 | [
"Q96DB2"
] | 3 | 13479724-13506424 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB080427"
] | [] | [
"Enzymes",
"FDA approved drug targets",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Hydrolase",
"Repressor"
] | [
"FDA approved drug targets"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | null | null | 15 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 11: White matter - Signal transduction | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 6 | Low immune cell specificity | Detected in many | null | 3 | 4 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,843 | 8 |
ENSG00000163518 | FCRL4 | Fc receptor like 4 | [
"Q96PJ5"
] | 1 | 157573747-157598085 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA054030"
] | [
"CD307d",
"FCRH4",
"IGFP2",
"IRTA1"
] | [
"Cancer-related genes",
"CD markers",
"Disease related genes",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [
"Receptor"
] | [
"Cancer-related genes"
] | [] | [] | [] | [] | null | Approved | null | 8 | null | null | null | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in some | 7 | Cancer enriched | Detected in single | 5 | Not detected | Not detected | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,844 | 3 |
ENSG00000163519 | TRAT1 | T cell receptor associated transmembrane adaptor 1 | [
"Q6PIZ9"
] | 3 | 108822770-108855005 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA002356",
"CAB026130",
"HPA072760"
] | [
"HSPC062",
"TCRIM",
"TRIM"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Plasma membrane"
] | [
"Mitotic spindle",
"Centriolar satellite"
] | [] | [] | Enhanced | Enhanced | null | 2 | Yes | null | Cluster 5: Non-specific - Cell proliferation | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in some | 26 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,845 | 2 |
ENSG00000163520 | FBLN2 | Fibulin 2 | [
"P98095"
] | 3 | 13549125-13638422 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001934",
"CAB018622"
] | [] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [
"Secreted to extracellular matrix"
] | [
"No annotated function"
] | Uncertain | Enhanced | null | 12 | null | null | Cluster 18: Non-specific - Translation | Cluster 51: Neurons - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Rectum Adenocarcinoma"
] | 10,846 | 7 |
ENSG00000163521 | GLB1L | Galactosidase beta 1 like | [
"Q6UWU2"
] | 2 | 219236598-219245478 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA043058"
] | [
"MGC10771"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Glycosidase",
"Hydrolase"
] | [] | [] | [] | [
"Secreted - unknown location"
] | [
"Enzyme"
] | null | Enhanced | null | 2 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 3: Choroid plexus - Cilium | Cluster 69: Skin cancer - ECM organization | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,847 | 8 |
ENSG00000163527 | STT3B | STT3 oligosaccharyltransferase complex catalytic subunit B | [
"Q8TCJ2"
] | 3 | 31532638-31637616 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036448",
"HPA036646"
] | [
"FLJ90106",
"SIMP",
"STT3-B"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Approved | null | 105 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 21: Non-specific - Metabolism | Cluster 8: Non-specific - Basic cellular processes | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,848 | 5 |
ENSG00000163528 | CHCHD4 | Coiled-coil-helix-coiled-coil-helix domain containing 4 | [
"Q8N4Q1"
] | 3 | 14112077-14124870 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034688",
"HPA063727"
] | [
"FLJ31709",
"MIA40",
"TIMM40"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Translocation",
"Transport"
] | [
"Oxidoreductase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Supported | Uncertain | null | 7 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 14: Neurons - Synaptic function | Cluster 8: Non-specific - Basic cellular processes | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 10,849 | 2 |
ENSG00000163530 | DPPA2 | Developmental pluripotency associated 2 | [
"Q7Z7J5"
] | 3 | 109293788-109316517 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036134"
] | [
"CT100",
"PESCRG1"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | 6 | null | null | null | null | Cluster 15: Kidney cancer - Membrane components | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in single | 9 | Group enriched | Detected in some | 4 | Cancer enriched | Detected in some | 24 | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,850 | 7 |
ENSG00000163534 | FCRL1 | Fc receptor like 1 | [
"Q96LA6"
] | 1 | 157794403-157820120 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA013323"
] | [
"CD307a",
"FCRH1",
"IFGP1",
"IRTA5"
] | [
"CD markers",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | Enhanced | null | null | null | null | Cluster 14: Non-specific - Unknown function | null | Cluster 46: Lymphoma - Humoral immune response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 18: Lymphoid tissue - Immune response | Group enriched | Detected in some | 16 | Cancer enriched | Detected in single | 36 | Not detected | Not detected | null | Cell type enriched | Detected in some | 4 | Group enriched | Detected in some | 49 | 0 | 0 | 0 | [] | [] | [] | 10,852 | 1 |
ENSG00000163535 | SGO2 | Shugoshin 2 | [
"Q562F6"
] | 2 | 200510008-200584096 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035163",
"HPA040817"
] | [
"FLJ25211",
"SGOL2",
"TRIPIN"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Chromosome partition",
"Meiosis"
] | [] | [] | [
"Nucleoplasm"
] | [
"Nuclear bodies"
] | [] | [] | Enhanced | Enhanced | null | 11 | null | Yes | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 2 | 3 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,853 | 5 |
ENSG00000163536 | SERPINI1 | Serpin family I member 1 | [
"Q99574"
] | 3 | 167735243-167825569 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001565",
"HPA056092"
] | [
"PI12"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Protease inhibitor",
"Serine protease inhibitor"
] | [
"Disease variant",
"Neurodegeneration"
] | [
"Cytosol"
] | [] | [
"Secreted in brain"
] | [
"Enzyme inhibitor"
] | Uncertain | Enhanced | null | 2 | null | null | Cluster 24: Non-specific - Transcription | Cluster 53: Neurons - Mixed function | Cluster 70: DU4475 - Unknown function | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 3: Oligodendrocytes - Myelination | Group enriched | Detected in all | 5 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,854 | 1 |
ENSG00000163539 | CLASP2 | Cytoplasmic linker associated protein 2 | [
"O75122"
] | 3 | 33496245-33718356 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067071"
] | [
"KIAA0627"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [] | [
"Golgi apparatus"
] | [
"Cytosol"
] | [] | [] | Supported | null | null | 56 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 10,855 | 3 |
ENSG00000163541 | SUCLG1 | Succinate-CoA ligase GDP/ADP-forming subunit alpha | [
"P53597"
] | 2 | 84423528-84460045 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036683",
"HPA036684"
] | [] | [
"Citric acid cycle related proteins",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Tricarboxylic acid cycle"
] | [
"Ligase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 8 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 21: Non-specific - Metabolism | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 97: Non-specific - Cellular respiration | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,856 | 3 |
ENSG00000163554 | SPTA1 | Spectrin alpha, erythrocytic 1 | [
"P02549"
] | 1 | 158610704-158686715 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016193",
"HPA028048",
"HPA028253",
"CAB037246"
] | [
"EL2"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell shape"
] | [
"Actin capping",
"Actin-binding"
] | [
"Disease variant",
"Elliptocytosis",
"Hereditary hemolytic anemia",
"Pyropoikilocytosis"
] | [] | [] | [] | [] | null | Enhanced | null | 21 | null | null | null | null | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in some | 45 | Cancer enriched | Detected in single | 18 | Not detected | Not detected | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,858 | 8 |
ENSG00000163558 | PRKCI | Protein kinase C iota | [
"P41743"
] | 3 | 170222424-170305977 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026574",
"HPA038635"
] | [
"DXS1179E",
"PKCI"
] | [
"Cancer-related genes",
"Enzymes",
"FDA approved drug targets",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Cancer-related genes",
"FDA approved drug targets",
"Proto-oncogene",
"Tumor suppressor"
] | [
"Cytosol"
] | [
"Microtubules",
"Cytokinetic bridge",
"Primary cilium"
] | [] | [] | Supported | Approved | null | 67 | Yes | No | Cluster 3: Non-specific - Nuclear processes | Cluster 14: Neurons - Synaptic function | Cluster 15: Kidney cancer - Membrane components | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,859 | 5 |
ENSG00000163563 | MNDA | Myeloid cell nuclear differentiation antigen | [
"P41218"
] | 1 | 158831351-158849506 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034532",
"HPA073215"
] | [
"PYHIN3"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli",
"Nucleoli rim",
"Vesicles",
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 22 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Group enriched | Detected in all | 4 | Group enriched | Detected in some | 20 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in all | 4 | 0 | 0 | 0 | [] | [] | [] | 10,860 | 2 |
ENSG00000163564 | PYHIN1 | Pyrin and HIN domain family member 1 | [
"Q6K0P9"
] | 1 | 158930796-158977059 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051224",
"HPA055373"
] | [
"IFIX",
"MGC23885"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle"
] | [] | [
"Tumor suppressor"
] | [
"Nucleoli"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 37 | null | null | Cluster 1: T-cells - Unknown function | Cluster 6: Non-specific - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in many | 4 | Cancer enriched | Detected in some | 6 | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 9 | Group enriched | Detected in many | 4 | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 10,861 | 8 |
ENSG00000163568 | AIM2 | Absent in melanoma 2 | [
"O14862"
] | 1 | 159061599-159187843 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031365",
"HPA040309"
] | [
"PYHIN4"
] | [
"Predicted intracellular proteins"
] | [
"DNA damage",
"Immunity",
"Inflammatory response",
"Innate immunity"
] | [
"DNA-binding"
] | [
"Tumor suppressor"
] | [
"Mitochondria"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 4 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 36: Choroid plexus - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 3 | 0 | 3 | [
"Glioblastoma Multiforme"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 10,863 | 9 |
ENSG00000163576 | EFHB | EF-hand domain family member B | [
"Q8N7U6"
] | 3 | 19879472-19947025 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034835"
] | [
"CFAP21",
"FLJ25200"
] | [
"Predicted intracellular proteins"
] | [
"Calcium transport",
"Ion transport",
"Transport"
] | [] | [] | [
"Cytosol"
] | [
"Nuclear bodies",
"Vesicles",
"Connecting piece"
] | [] | [] | Approved | null | null | 1 | null | null | null | Cluster 46: Brainstem - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,864 | 5 |
ENSG00000163577 | EIF5A2 | Eukaryotic translation initiation factor 5A2 | [
"Q9GZV4"
] | 3 | 170888418-170908644 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029090"
] | [] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein biosynthesis"
] | [
"Elongation factor",
"RNA-binding"
] | [] | [
"Vesicles"
] | [] | [] | [] | Supported | Approved | null | 14 | null | null | Cluster 1: T-cells - Unknown function | Cluster 45: Non-specific - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 57: Testis - Spermatogenesis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 10,865 | 4 |
ENSG00000163581 | SLC2A2 | Solute carrier family 2 member 2 | [
"P11168"
] | 3 | 170996347-171026743 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB010444",
"HPA028997",
"HPA069490"
] | [
"GLUT-2",
"GLUT2"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Sugar transport",
"Transport"
] | [] | [
"Disease variant"
] | [
"Plasma membrane",
"Mid piece",
"Principal piece"
] | [] | [] | [] | Supported | Enhanced | null | 3 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 15: Kidney cancer - Membrane components | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in some | 13 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in some | 9 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,866 | 5 |
ENSG00000163584 | RPL22L1 | Ribosomal protein L22 like 1 | [
"Q6P5R6"
] | 3 | 170864875-170870208 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048060",
"HPA056207",
"HPA068294"
] | [] | [
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Nucleoli"
] | [
"Nucleoplasm",
"Nucleoli rim"
] | [] | [] | Approved | Uncertain | null | 16 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 42: Non-specific - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 10,867 | 1 |
ENSG00000163586 | FABP1 | Fatty acid binding protein 1 | [
"P07148"
] | 2 | 88122982-88128062 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002305",
"HPA028275"
] | [
"L-FABP"
] | [
"Cancer-related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transport"
] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 3 | null | null | null | null | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 26: Kidney & Intestine - Metabolism | Group enriched | Detected in many | 12 | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 13 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,868 | 8 |
ENSG00000163590 | PPM1L | Protein phosphatase, Mg2+/Mn2+ dependent 1L | [
"Q5SGD2"
] | 3 | 160755602-161078902 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA019891",
"HPA019953"
] | [
"PP2CE"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 21: Lymphoma - Adaptive immune response | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 2 | 1 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,869 | 7 |
ENSG00000163596 | ICA1L | Islet cell autoantigen 1 like | [
"Q8NDH6"
] | 2 | 202773150-202871766 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042507"
] | [
"ALS2CR14",
"ALS2CR15"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 65: Brain - Transcription | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 10,870 | 5 |
ENSG00000163599 | CTLA4 | Cytotoxic T-lymphocyte associated protein 4 | [
"P16410"
] | 2 | 203853888-203873965 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CD",
"CD152",
"CELIAC3",
"CTLA-4",
"GSE",
"IDDM12"
] | [
"CD markers",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [
"Diabetes mellitus",
"Disease variant",
"FDA approved drug targets",
"Systemic lupus erythematosus"
] | [] | [] | [] | [] | null | null | null | 13 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 39: Astrocytes - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in many | 6 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in some | 9 | Immune cell enriched | Detected in some | 7 | 3 | 0 | 3 | [
"Head and Neck Squamous Cell Carcinoma",
"Skin Cutaneous Melanoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Skin Cutaneous Melanoma"
] | 10,871 | 9 |
ENSG00000163600 | ICOS | Inducible T cell costimulator | [
"Q9Y6W8"
] | 2 | 203936763-203961577 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB032575",
"HPA034865"
] | [
"AILIM",
"CD278"
] | [
"CD markers",
"Disease related genes",
"Human disease related genes",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Actin filaments"
] | [
"Intracellular and membrane"
] | [
"No annotated function"
] | Approved | Approved | null | 5 | null | null | Cluster 31: T-cells - T-cell receptor | null | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in some | 7 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 7 | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | 10,872 | 3 |
ENSG00000163602 | RYBP | RING1 and YY1 binding protein | [
"Q8N488"
] | 3 | 72371825-72446621 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053357"
] | [
"AAP1",
"DEDAF",
"YEAF1"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 124 | null | No | null | Cluster 34: Non-specific - Mixed function | Cluster 8: Non-specific - Basic cellular processes | Cluster 80: Oligodendrocytes - Myelination | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,873 | 2 |
ENSG00000163606 | CD200R1 | CD200 receptor 1 | [
"Q8TD46"
] | 3 | 112921205-112975103 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA068512"
] | [
"CD200R",
"HCRTR2",
"MOX2R",
"OX2R"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Host-virus interaction"
] | [
"Receptor"
] | [] | [
"Plasma membrane"
] | [] | [
"Intracellular and membrane"
] | [
"Receptor"
] | Supported | null | null | 1 | null | null | Cluster 46: Basophils - Proteolysis | Cluster 23: Choroid plexus - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 4 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 10,875 | 5 |
ENSG00000163607 | GTPBP8 | GTP binding protein 8 (putative) | [
"Q8N3Z3"
] | 3 | 112990984-113015060 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034831",
"HPA058631"
] | [
"HSPC135"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Enhanced | Approved | null | 1 | No | No | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 17: Non-specific - RNA processing | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 10,876 | 8 |
ENSG00000163608 | NEPRO | Nucleolus and neural progenitor protein | [
"Q6NW34"
] | 3 | 113002444-113019861 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA069654"
] | [
"C3orf17",
"DKFZP434F2021",
"NET17"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Developmental protein"
] | [
"Disease variant",
"Dwarfism"
] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Supported | null | null | 21 | Yes | No | Cluster 24: Non-specific - Transcription | Cluster 55: Non-specific - Transcription | Cluster 71: Lymphoma - Inflammatory response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,877 | 6 |
ENSG00000163611 | SPICE1 | Spindle and centriole associated protein 1 | [
"Q8N0Z3"
] | 3 | 113442718-113515187 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA064843"
] | [
"CCDC52",
"SPICE"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [] | [
"Centrosome",
"Basal body"
] | [] | [] | [] | Supported | Approved | null | 26 | null | null | Cluster 41: Basophils - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,878 | 1 |
ENSG00000163617 | CCDC191 | Coiled-coil domain containing 191 | [
"Q8NCU4"
] | 3 | 113964137-114056594 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA047833"
] | [
"KIAA1407"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 34: B-cells - Unknown function | Cluster 3: Choroid plexus - Cilium | Cluster 55: Lymphoma - Immune response | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 10,879 | 5 |
ENSG00000163618 | CADPS | Calcium dependent secretion activator | [
"Q9ULU8"
] | 3 | 62398346-62875416 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059328"
] | [
"CAPS",
"CAPS1",
"KIAA1121",
"UNC-31"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Exocytosis",
"Protein transport",
"Transport"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Enhanced | Supported | 1 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 1: Neuronal - Visual perception | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 10,880 | 4 |
ENSG00000163623 | NKX6-1 | NK6 homeobox 1 | [
"P78426"
] | 4 | 84491985-84499292 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036774",
"CAB070169"
] | [
"Nkx6.1",
"NKX6A"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 1 | null | null | null | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 12: Bone cancer - Neuronal signaling | Cluster 76: Pancreatic endocrine cells - Endocrine signaling | Cluster 11: Esophagus - Basic cellular processes | Group enriched | Detected in some | 6 | Cancer enriched | Detected in many | 5 | Cancer enriched | Detected in many | 9 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 10,881 | 8 |
ENSG00000163625 | WDFY3 | WD repeat and FYVE domain containing 3 | [
"Q8IZQ1"
] | 4 | 84668765-84966690 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA042734",
"HPA048572"
] | [
"ALFY",
"KIAA0993",
"ZFYVE25"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Autophagy"
] | [
"Developmental protein"
] | [
"Disease variant",
"Primary microcephaly"
] | [
"Cytosol"
] | [
"Nucleoli",
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 25 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 13: Oligodendrocytes - Mixed function | Cluster 48: Adipocytes & Endothelial cells - Angiogenesis | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 46: Brain & retina - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enriched | Detected in single | 5 | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,883 | 3 |
ENSG00000163626 | COX18 | Cytochrome c oxidase assembly factor COX18 | [
"Q8N8Q8"
] | 4 | 73052362-73069755 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA046772",
"HPA049489"
] | [
"FLJ38991",
"OXA1L2"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | Approved | null | null | null | null | null | Cluster 9: Non-specific - Receptor signaling | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in some | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in single | null | Low cell type specificity | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,884 | 2 |
ENSG00000163629 | PTPN13 | Protein tyrosine phosphatase non-receptor type 13 | [
"Q12923"
] | 4 | 86594315-86815171 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB002213",
"HPA065290"
] | [
"PTP-BAS",
"PTP-BL",
"PTP1E",
"PTPL1"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [
"Cancer-related genes"
] | [
"Plasma membrane",
"Primary cilium"
] | [
"Primary cilium transition zone",
"Basal body",
"Cytosol"
] | [] | [] | Approved | Approved | null | 33 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 55: Non-specific - Transcription | Cluster 1: Neuronal - Visual perception | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 42: Retina - Visual perception | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,885 | 4 |
ENSG00000163630 | SYNPR | Synaptoporin | [
"Q8TBG9"
] | 3 | 63228315-63616924 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051368",
"HPA061671"
] | [
"MGC26651",
"SPO"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Vesicles"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 10 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 10: Brain - Synaptic signal transduction | Tissue enriched | Detected in some | 7 | Group enriched | Detected in some | 4 | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,886 | 4 |
ENSG00000163631 | ALB | Albumin | [
"P02768"
] | 4 | 73397114-73421482 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB006262",
"HPA031024",
"HPA031025"
] | [] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Disease related genes",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets"
] | [
"Endoplasmic reticulum",
"Golgi apparatus"
] | [] | [
"Secreted to blood"
] | [
"Transport"
] | Approved | Enhanced | null | 27 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in many | 134 | Cancer enriched | Detected in many | 24 | Cancer enriched | Detected in many | 407 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,887 | 6 |
ENSG00000163632 | C3orf49 | Chromosome 3 open reading frame 49 | [
"Q96BT1"
] | 3 | 63819299-63848636 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [
"HPA053582"
] | [] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [
"Vesicles",
"Centrosome"
] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 40: Non-specific - Mixed function | Low tissue specificity | Detected in some | null | Not detected | Not detected | null | Low cancer specificity | Detected in single | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | 10,888 | 8 |
ENSG00000163633 | C4orf36 | Chromosome 4 open reading frame 36 | [
"Q96KX1"
] | 4 | 86876205-86892422 | Evidence at transcript level | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | [
"HPA057434"
] | [
"MGC26744"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Focal adhesion sites",
"Cytosol"
] | [
"Vesicles"
] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 71: Lymphoma - Inflammatory response | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 47: Testis - Mixed function | Tissue enriched | Detected in some | 7 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in single | null | Group enriched | Detected in many | 17 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,889 | 4 |
ENSG00000163634 | THOC7 | THO complex subunit 7 | [
"Q6I9Y2"
] | 3 | 63833870-63863868 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044143"
] | [
"FLJ23445",
"fSAP24",
"NIF3L1BP1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing",
"mRNA transport",
"Transport"
] | [
"RNA-binding"
] | [] | [
"Nuclear speckles",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 48 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 14: Neurons - Synaptic function | Cluster 8: Non-specific - Basic cellular processes | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 10,890 | 8 |
ENSG00000163636 | PSMD6 | Proteasome 26S subunit, non-ATPase 6 | [
"Q15008"
] | 3 | 64010550-64024010 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036921",
"HPA036922"
] | [
"KIAA0107",
"p44S10",
"Rpn7",
"S10"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 167 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 27: Non-specific - Mixed function | Cluster 8: Non-specific - Basic cellular processes | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 8: Pancreas - Proteolysis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 10,892 | 7 |
ENSG00000163637 | PRICKLE2 | Prickle planar cell polarity protein 2 | [
"Q7Z3G6"
] | 3 | 64092236-64445476 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035493"
] | [
"DKFZp686D143"
] | [
"Disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Epilepsy",
"Neurodegeneration",
"Neuropathy"
] | [
"Golgi apparatus"
] | [
"Vesicles"
] | [] | [] | Approved | null | null | null | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 10,893 | 3 |
ENSG00000163638 | ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif 9 | [
"Q9P2N4"
] | 3 | 64515654-64688000 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028567",
"HPA028577",
"HPA028601"
] | [
"KIAA1312"
] | [
"Cancer-related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum"
] | [
"Vesicles"
] | [
"Secreted to extracellular matrix"
] | [
"Transport"
] | Supported | Approved | null | null | No | null | null | Cluster 44: Non-specific - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,894 | 2 |
ENSG00000163645 | ERICH6 | Glutamate rich 6 | [
"Q7L0X2"
] | 3 | 150659885-150703971 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA048373"
] | [
"C3orf44",
"ERICH6A",
"FAM194A",
"MGC39662"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 33: Neurons - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 77: Late primary spermatocytes - Spermiogenesis: Golgi Phase | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in some | 17 | Low cancer specificity | Detected in some | null | Low cancer specificity | Detected in some | null | Group enriched | Detected in many | 6 | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 10,896 | 4 |
ENSG00000163646 | CLRN1 | Clarin 1 | [
"P58418"
] | 3 | 150926163-150972727 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA054031"
] | [
"RP61",
"USH3",
"USH3A"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Hearing",
"Sensory transduction",
"Vision"
] | [] | [
"Deafness",
"Disease variant",
"Retinitis pigmentosa",
"Usher syndrome"
] | [
"Centrosome"
] | [
"Vesicles",
"Basal body"
] | [] | [] | Uncertain | null | null | 23 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 11: Neuronal - Sensory perception | Cluster 11: Muller glia cells - Retinal homeostasis | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in some | 7 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enriched | Detected in some | 8 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 10,897 | 6 |
ENSG00000163655 | GMPS | Guanine monophosphate synthase | [
"P49915"
] | 3 | 155870650-155944020 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046630"
] | [
"GATD7"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"GMP biosynthesis",
"Purine biosynthesis"
] | [
"Ligase"
] | [
"Proto-oncogene"
] | [
"Mitochondria",
"Cytosol"
] | [] | [] | [] | Supported | null | null | 10 | No | No | Cluster 33: Non-specific - ATP binding | Cluster 16: Non-specific - Transcription | Cluster 63: Non-specific - Protein processing | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 5 | 6 | 2 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Thyroid Carcinoma"
] | 10,898 | 1 |
ENSG00000163659 | TIPARP | TCDD inducible poly(ADP-ribose) polymerase | [
"Q7Z3E1"
] | 3 | 156673235-156706770 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036796"
] | [
"ARTD14",
"DDF1",
"DKFZP434J214",
"DKFZp686N0351",
"PARP-1",
"PARP-7",
"PARP7",
"pART14",
"RM1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Glycosyltransferase",
"Nucleotidyltransferase",
"Transferase"
] | [] | [
"Microtubules"
] | [] | [] | [] | Approved | null | null | 3 | null | null | Cluster 41: Basophils - Unknown function | Cluster 39: Astrocytes - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 103: Non-specific - Basic cellular processes | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enhanced | Detected in all | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 10,899 | 2 |
ENSG00000163660 | CCNL1 | Cyclin L1 | [
"Q9UK58"
] | 3 | 157146508-157160760 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA057911"
] | [
"ania-6a"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Transcription",
"Transcription regulation"
] | [
"Cyclin"
] | [
"Proto-oncogene"
] | [
"Nucleoplasm",
"Nuclear bodies"
] | [] | [] | [] | Supported | null | null | 42 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 6: Non-specific - Immune response | Cluster 30: Non-specific - Gene expression regulation | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 10,900 | 2 |
ENSG00000163661 | PTX3 | Pentraxin 3 | [
"P26022"
] | 3 | 157436850-157443633 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA069320"
] | [
"TNFAIP5",
"TSG-14"
] | [
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [
"Secreted to blood"
] | [
"No annotated function"
] | Uncertain | Approved | null | 10 | null | null | Cluster 19: Eosinophils - Unknown function | Cluster 12: Non-specific - Vasculature | Cluster 64: Connective tissue cells - ECM organization | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 7 | 0 | 7 | [] | [
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 10,901 | 6 |
ENSG00000163666 | HESX1 | HESX homeobox 1 | [
"Q9UBX0"
] | 3 | 57197838-57227606 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA024187"
] | [
"ANF",
"RPX"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Disease variant",
"Dwarfism"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 13 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 20: Myeloma - Immune response | Cluster 3: Early primary spermatocytes - Early meiosis | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in many | 4 | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 3 | 0 | 3 | [] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | 10,902 | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.